OA06373A - Nouvelles compositions pharmaceutiques à base d'aryltrifluoroétanols. - Google Patents

Nouvelles compositions pharmaceutiques à base d'aryltrifluoroétanols.

Info

Publication number
OA06373A
OA06373A OA56934A OA56934A OA06373A OA 06373 A OA06373 A OA 06373A OA 56934 A OA56934 A OA 56934A OA 56934 A OA56934 A OA 56934A OA 06373 A OA06373 A OA 06373A
Authority
OA
OAPI
Prior art keywords
aryltrifluoroetanols
pharmaceutical compositions
compositions based
new pharmaceutical
new
Prior art date
Application number
OA56934A
Other languages
English (en)
French (fr)
Inventor
Michel Vincent
Georges Remond
Jacques Bure
Original Assignee
Science Union & Cie
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Science Union & Cie filed Critical Science Union & Cie
Publication of OA06373A publication Critical patent/OA06373A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/08—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms
    • C07D295/096—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms separated by carbocyclic rings or by carbon chains interrupted by carbocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
    • C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D211/26—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by nitrogen atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pain & Pain Management (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Hydrogenated Pyridines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pyridine Compounds (AREA)
OA56934A 1978-11-03 1979-11-03 Nouvelles compositions pharmaceutiques à base d'aryltrifluoroétanols. OA06373A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR7831096A FR2440353A1 (fr) 1978-11-03 1978-11-03 Nouveaux arylethanols, leurs procedes d'obtention et leur emploi comme medicament

Publications (1)

Publication Number Publication Date
OA06373A true OA06373A (fr) 1981-08-31

Family

ID=9214422

Family Applications (2)

Application Number Title Priority Date Filing Date
OA56934A OA06373A (fr) 1978-11-03 1979-11-03 Nouvelles compositions pharmaceutiques à base d'aryltrifluoroétanols.
OA56933A OA06372A (fr) 1978-11-03 1979-11-03 Nouveaux aryltrifluoroéthanols, leur procédé d'obtention et leur emploi en thérapeutique.

Family Applications After (1)

Application Number Title Priority Date Filing Date
OA56933A OA06372A (fr) 1978-11-03 1979-11-03 Nouveaux aryltrifluoroéthanols, leur procédé d'obtention et leur emploi en thérapeutique.

Country Status (27)

Country Link
US (2) US4285943A (da)
JP (2) JPS5566548A (da)
AR (2) AR223989A1 (da)
AT (1) AT368483B (da)
AU (1) AU527630B2 (da)
BE (2) BE879786A (da)
CA (2) CA1142087A (da)
CH (2) CH641043A5 (da)
DD (2) DD151445A5 (da)
DE (2) DE2944293A1 (da)
DK (2) DK461679A (da)
EG (1) EG14114A (da)
ES (1) ES485656A0 (da)
FI (2) FI793444A (da)
FR (1) FR2440353A1 (da)
GB (2) GB2038802B (da)
GR (2) GR68015B (da)
IL (2) IL58620A (da)
IT (2) IT7950714A0 (da)
MA (2) MA18629A1 (da)
NL (2) NL7908099A (da)
NZ (2) NZ192020A (da)
OA (2) OA06373A (da)
PT (2) PT70407A (da)
SE (2) SE7909105L (da)
SU (1) SU925247A3 (da)
ZA (2) ZA795871B (da)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5965606A (en) * 1995-12-29 1999-10-12 Allergan Sales, Inc. Methods of treatment with compounds having RAR.sub.α receptor specific or selective activity
US6673784B1 (en) * 1996-03-19 2004-01-06 G. D. Searle & Co. Electrophilic ketones for the treatment of herpesvirus infections
ITRM20050389A1 (it) 2005-07-22 2007-01-23 Giuliani Spa Composti e loro sali specifici per i recettori ppar ed i recettori per l'egf e loro uso in campo medico.
UA107562C2 (uk) 2008-12-05 2015-01-26 Спосіб лікування псоріазу
MX2011008601A (es) 2009-02-16 2011-09-09 Giuliani Int Ltd Compuestos de alquilamido y usos de los mismos.
CN104254327A (zh) 2012-02-09 2014-12-31 诺格拉制药有限公司 治疗纤维化的方法
IN2014DN08157A (da) 2012-04-18 2015-05-01 Nogra Pharma Ltd
KR20210125047A (ko) 2019-02-08 2021-10-15 노그라 파마 리미티드 3-(4'-아미노페닐)-2-메톡시프로피온산, 및 그의 유사체 및 중간체의 제조 방법

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3142683A (en) * 1961-08-14 1964-07-28 Parke Davis & Co 1-pyridyl-1, 2-diaryl-3-trifluoro-propan-2-ols and a process for their preparation
US3531487A (en) * 1966-10-25 1970-09-29 Hoffmann La Roche 4-(n,n-disubstituted-amino)-piperidines
DE1618007A1 (de) * 1967-05-09 1970-10-29 Thomae Gmbh Dr K Verfahren zur Herstellung von neuen Amino-monohalogenphenylaethanolaminen
US3821231A (en) * 1971-10-15 1974-06-28 E Lavrinovich Method for preparation of n-substituted 4-aniline piperidines
GB1411783A (en) * 1972-02-24 1975-10-29 Wyeth John & Brother Ltd Piperidine derivatives
FR2340734A1 (fr) * 1976-02-13 1977-09-09 Roussel Uclaf Nouveaux derives de la m-trifluoromethylphenyl piperidine et leurs sels, procede de preparation et application a titre de medicaments
DE2659117A1 (de) * 1976-12-28 1978-07-06 Consortium Elektrochem Ind Trichlormethyl-(3-pyridyl)-carbinol
DE2843776A1 (de) * 1977-10-07 1979-04-12 Science Union & Cie (arylalkyl)-alkansaeurederivate, verfahren zu ihrer herstellung und sie enthaltende arzneimittel

Also Published As

Publication number Publication date
EG14114A (en) 1983-03-31
ATA701679A (de) 1982-02-15
FI793444A (fi) 1980-05-04
IT7950714A0 (it) 1979-10-31
MA18628A1 (fr) 1980-07-01
IL58621A0 (en) 1980-02-29
FI793445A (fi) 1980-05-04
GB2038802A (en) 1980-07-30
US4285943A (en) 1981-08-25
AR223989A1 (es) 1981-10-15
NZ192020A (en) 1982-12-21
ZA795871B (en) 1980-10-29
OA06372A (fr) 1981-08-31
GB2034587B (en) 1983-02-09
DE2944293A1 (de) 1980-05-08
AT368483B (de) 1982-10-11
DD147048A5 (de) 1981-03-18
IL58620A (en) 1982-12-31
DE2944294A1 (de) 1980-05-08
SE7909105L (sv) 1980-05-04
DK461679A (da) 1980-05-04
CA1142087A (fr) 1983-03-01
BE879787A (fr) 1980-04-30
BE879786A (fr) 1980-04-30
ES8101538A1 (es) 1980-12-16
SU925247A3 (ru) 1982-04-30
PT70407A (en) 1979-12-01
GB2038802B (en) 1982-12-08
JPS5566510A (en) 1980-05-20
AR223990A1 (es) 1981-10-15
GR69726B (da) 1982-07-09
IT7950715A0 (it) 1979-10-31
CH641043A5 (fr) 1984-02-15
FR2440353A1 (fr) 1980-05-30
AU527630B2 (en) 1983-03-17
NZ192021A (en) 1982-09-07
MA18629A1 (fr) 1980-07-01
PT70408A (fr) 1979-12-01
SE7909106L (sv) 1980-05-04
DK461579A (da) 1980-05-04
GB2034587A (en) 1980-06-11
IL58620A0 (en) 1980-02-29
ES485656A0 (es) 1980-12-16
CA1139763A (fr) 1983-01-18
AU5241679A (en) 1980-05-08
JPS5566548A (en) 1980-05-20
US4404215A (en) 1983-09-13
GR68015B (da) 1981-10-27
CH647225A5 (fr) 1985-01-15
ZA795870B (en) 1980-10-29
NL7908099A (nl) 1980-05-07
NL7908101A (nl) 1980-05-07
DD151445A5 (de) 1981-10-21

Similar Documents

Publication Publication Date Title
OA05847A (fr) Compositions fongicides à base d'alcoylphosphites.
FR2344290A1 (fr) Nouvelles compositions pharmaceutiques anti-inflammatoires
BE858003A (fr) Compositions pharmaceutiques a base d'alginate de sodium
IT7928464A0 (it) Composizione farmaceutica avente attivita' antitumorale.
BE858522A (fr) Compositions pharmaceutiques a base d'anthocyanidine, leur preparation et leur utilisation
FR2341637A1 (fr) Nouvelles compositions d'aerosol
OA06197A (fr) Insecticide à base d'hydrazone.
NL990010I2 (nl) Ä3HÜ-imidazo-Ä5,1-dÜ-1,2,3,5-tetrazine-4-on derivaten en farmaceutische samenstellingen, die deze d erivaten bevatten.
NL7607325A (nl) Zeilmast voor zeilski's.
IT1209454B (it) Composizione farmaceutica a base di estratti di mirtillo.
FR2600253B1 (fr) Nouvelles compositions pharmaceutiques a base de ketotifene
IT1126406B (it) 1,2,4,5-tetra-alchil-4-arilpiperidine e relative formulazioni farmaceutiche
IT7822019A0 (it) Composizione farmaceutica adattivita' antibroncospastica e antitosse.
IT7926662A0 (it) Composizione farmaceutica contenente 3,4-di-idro-3-osso-2-chinossaline.
MX9203148A (es) 2,6-dialcoxipenzamidas y composiciones farmaceuticas que las contienen.
BE874628A (fr) Nouvelles compositions pharmaceutiques a base de peptide monocyclique
OA06373A (fr) Nouvelles compositions pharmaceutiques à base d'aryltrifluoroétanols.
IT7920567A0 (it) Meccanismo d'interbloccaggio di formulazione d'indirizzo.
NO790313L (no) Farmasoeytisk opploesning.
BE873481A (fr) Nouvelles compositions pharmaceutiques a base de prostaglandines
BE890311A (fr) Nouvelles compositions pharmaceutiques a base d'un derive de la 1,4-dihydropyridine
IT8019430A0 (it) Formulazione farmaceutica a cessione protratta.
OA05310A (fr) Compositions fongicides à base d'hypophosphites.
NL190120C (nl) 2,3-dihydro-4h-1-benzopyran-4-on-0-carbamoyloximen alsmede farmaceutisch preparaat daarvan.
IT8025835A0 (it) Ftalazinolo. composizione farmaceutica a base di